Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Novo Nordisk
Novo Nordisk
JPM24: In booming obesity field, Novo Nordisk is 'just getting going,' CEO says
Fierce Pharma
Wed, 01/10/24 - 06:27 pm
Novo Nordisk
obesity
Wegovy
Lars Fruergaard Jorgensen
JPMHC 2024
Ozempic not tied to pancreatic cancer risk, study suggests
Beckers Hospital Review
Tue, 01/9/24 - 10:04 pm
Ozempic
Trulicity
type 2 diabetes
Novo Nordisk
GLP-1 agonist
pancreatic cancer
Novo CEO expects patients to stay on Wegovy longer than older weight loss drugs
Reuters
Tue, 01/9/24 - 09:59 pm
Novo Nordisk
Pharma CEOs
Wegovy
patients
Lars Fruergaard Jorgensen
JPMHC 2024
Wegovy, Ozempic not linked to increase in suicidal thoughts, US study finds
Reuters
Fri, 01/5/24 - 09:55 am
Novo Nordisk
Wegovy
Ozempic
side effects
Novo Nordisk, Eli Lilly's weight-loss drugs under FDA scrutiny for suicidal thoughts, hair loss
Fierce Pharma
Thu, 01/4/24 - 11:53 am
Novo Nordisk
Eli Lilly
weightloss
side effects
Ozempic
Wegovy
Zepbound
Novo Nordisk offers 2 Flagship biotechs up to $1B total for obesity, MASH deals
Fierce Biotech
Thu, 01/4/24 - 10:06 am
Novo Nordisk
Omega Therapeutics
Cellarity
Flagship Pioneering
funding
obesity
NASH
MASH
Novo Nordisk to open new AI research hub in London
Biopharma Reporter
Tue, 01/2/24 - 09:47 am
Novo Nordisk
artificial intelligence
London
UK
R&D
Novo Nordisk submits application for massive manufacturing campus near Dublin
Fierce Pharma
Sun, 12/31/23 - 11:57 am
Novo Nordisk
Ireland
drug manufacturing
Ozempic
Wegovy
FDA warns about counterfeit versions of Novo's diabetes drug Ozempic
Reuters
Fri, 12/22/23 - 09:40 am
Novo Nordisk
FDA
Ozempic
diabetes
drug counterfeiting
Obesity drugs’ next tests, and rising threats: 3 chronic disease stories to watch
Stat
Thu, 12/21/23 - 09:52 am
obesity
climate change
Wegovy
Zepbound
Novo Nordisk
Eli Lilly
liver disease
Obesity drug Mounjaro to surpass Ozempic with $27 billion sales in 2029
Biopharma Reporter
Mon, 12/18/23 - 11:37 am
Eli Lilly
Novo Nordisk
obesity
weight loss
Ozempic
Mounjaro
Novo owner commits $265 mln of Wegovy windfall to respiratory diseases
Reuters
Mon, 12/18/23 - 10:22 am
Novo Nordisk
Wegovy
vaccines
respiratory disease
IndiaMART is working with Novo Nordisk to halt illegal Wegovy sales -source
Reuters
Sun, 12/17/23 - 09:57 pm
India
Novo Nordisk
Wegovy
weight loss
Fractyl, hoping its GLP-1 gene therapy can take on Wegovy, plans IPO
Fierce Biotech
Fri, 12/15/23 - 09:41 am
Fractyl Health
IPOs
Novo Nordisk
Wegovy
GLP-1 agonist
US employers hire virtual providers as weight-loss drug gatekeepers
Reuters
Wed, 12/13/23 - 09:38 am
Novo Nordisk
Wegovy
weight loss
Teladoc
US diabetes patients face delays as insurers tighten Ozempic coverage
Reuters
Tue, 12/12/23 - 10:03 am
Novo Nordisk
type 2 diabetes
Ozempic
insurers
Could Eli Lilly Beat Novo Nordisk in the Billion-Dollar Weight Loss Market?
Motley Fool
Fri, 12/8/23 - 09:56 am
Eli Lilly
Novo Nordisk
weight loss
Wegovy
Zepbound
Adherence to weight-loss drugs is far higher with Wegovy than older medicines
Reuters
Wed, 12/6/23 - 10:36 am
Wegovy
Novo Nordisk
weight loss
patient adherence
As Ozempic cases mount, consumer lawyers push to consolidate lawsuits
Reuters
Mon, 12/4/23 - 06:05 pm
legal
weight loss
Ozempic
Wegovy
Novo Nordisk
side effects
Maker of Wegovy, Ozempic showers money on U.S. obesity doctors
Reuters
Mon, 12/4/23 - 09:35 am
Novo Nordisk
obesity
physicians
Wegovy
Ozempic
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »